Kiora Pharmaceuticals Inc. Skyrocketed
Tue, Feb 07, 2023 at 07:08 PM
Kiora Pharmaceuticals Inc. (KPRX:NASDAQ) shot up at $4.55, representing a gain of 38.7%. On Tue, Feb 07, 2023, KPRX:NASDAQ hit a New 2-Week High of $4.55. The stock appeared on our News Catalysts scanner on Tue, Feb 07, 2023 at 09:54 AM in the 'BIOTECH' category. From Tue, Jan 24, 2023, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Tue, Feb 07, 2023 at $5.89 with a volume of 28M+.
About Kiora Pharmaceuticals Inc. (KPRX:NASDAQ)
Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye.
Top 10 Gainers:
- SeqLL Inc. (SQL:NASDAQ), 185.19%
- SelectQuote Inc. (SLQT:NYSE), 70.83%
- iBio, Inc. (IBIO:NYSEMKT), 48.49%
- China Xiangtai Food Co. Ltd. (BTOG:NASDAQ), 40.35%
- Kiora Pharmaceuticals Inc. (KPRX:NASDAQ), 38.72%
- Versus Systems Inc. (VS:NASDAQ), 38.54%
- Impac Mortgage Holdings, Inc. (IMH:NYSEMKT), 32.88%
- Celyad SA (CYAD:NASDAQ), 32.76%
- Zhihu Inc. American Depositary Shares (every two of each representing one Class A) (ZH:NYSE), 31.69%
- Sidus Space Inc. (SIDU:NASDAQ), 30.41%